In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Endogen Inc.

Division of Thermo Fisher Scientific Inc.
www.endogen.com

Latest From Endogen Inc.

Innogenetics on its Own

Innogenetics, like many biotech companies, has built a diagnostics business in order to capture short-term revenues. But it got squeezed by industry consolidation and its response is an aggressive and expensive strategy to increase its emphasis on high-margin, novel tests, which it will use to fund conversion to a direct sales and marketing network in major markets.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Thermo Fisher Scientific Inc.
  • Senior Management
  • Owen A Dempsey, Pres. & CEO
    Alan Kotik, Dir., Mktg. & Bus. Dev.
    Dennis Walczewski, VP, Sales
    Christine A Burns, PhD, VP, Product Dev. & Technology
  • Contact Info
  • Endogen Inc.
    Phone: (781) 937-0890
    30 Commerce Way
    Woburn, MA 01801-1059
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register